A second study using IHC to assess prognostic significance of CD44 and CD24 expression in breast cancer also failed to find a correlation between the CD44highCD24− phenotype and tumor progression, although there was suggestion of a correlation with bone metastasis (Abraham et al., 2005). The gene discussed is CD44; the disease is breast cancer.